Clinical Trial

Early Initiated Ambulance-delivered Levetiracetam and Headposition in Hyper-acute Stroke Trial

Study acronym: EAST
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This is an investigator initiated and conducted, multicentre, ambulance-delivered, prospective, randomised, open-label, blinded outcome (PROBE) study. EAST aims to evaluate the effects of pre-hospital levetiracetam and different head positions initiated in ambulance settings on the functional outcome of participants assessed at 90 days.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-01-13.
Status change: Not Yet Recruiting → Recruiting 2025-05-19
Trial Details
NCT Number NCT06773364
Lead Sponsor Shanghai East Hospital
Conditions Suspected Stroke
Enrollment 2,423 participants
Start Date 2025-04-30
Primary Completion 2028-12-31 (estimated)
Study Completion 2029-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-22